The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside
Open accessAbstract
Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful pathogens in the modern healthcare system. With invasive procedures, antibiotic use and immunocompromised hosts increasing in recent years, A. baumannii has become endemic in hospitals due to its versatile genetic machinery, which allows it to quickly evolve resistance factors, and to its remarkable ability to tolerate harsh environments. Infections and outbreaks caused by multidrug-resistant A. baumannii (MDRAB) are prevalent and have been reported worldwide over the past twenty or more years. To address this problem effectively, knowledge of species identification, typing methods, clinical manifestations, risk factors, and virulence factors is essential. The global epidemiology of MDRAB is monitored by persistent surveillance programs. Because few effective antibiotics are available, clinicians often face serious challenges when treating patients with MDRAB. Therefore, a deep understanding of the resistance mechanisms used by MDRAB can shed light on two possible strategies to combat the dissemination of antimicrobial resistance: stringent infection control and antibiotic treatments, of which colistin-based combination therapy is the mainstream strategy. However, due to the current unsatisfying therapeutic outcomes, there is a great need to develop and evaluate the efficacy of new antibiotics and to understand the role of other potential alternatives, such as antimicrobial peptides, in the treatment of MDRAB infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
BIGSdb: Scalable analysis of bacterial genome variation at the population level
Jolley, K. A., & Maiden, M. C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-595 · Cited by 2,368
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Integrons: agents of bacterial evolution
Mazel, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1462 · Cited by 1,107
Antimicrobial peptides: premises and promises
Reddy, K. V. R., Yedery, R. D., & Aranha, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.005 · Cited by 1,068
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Maragakis, L. L., & Perl, T. M. (2008) · Clinical Infectious Diseases · doi:10.1086/529198 · Cited by 969
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., & Pitt, T. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01021-06 · Cited by 657
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
Giske, C. G., Monnet, D. L., Cars, O., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01169-07 · Cited by 610
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Genomic approaches to studying the human microbiota
Weinstock, G. M. (2012) · Nature · doi:10.1038/nature11553 · Cited by 539
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp
Coyne, S., Courvalin, P., & Périchon, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-10 · Cited by 505
Epithelial antimicrobial peptides in host defense against infection
Bals, R. (2000) · Respiratory Research · doi:10.1186/rr25 · Cited by 498
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
Gaddy, J. A., Tomaras, A. P., & Actis, L. A. (2009) · Infection and Immunity · doi:10.1128/iai.00096-09 · Cited by 482
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Smith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Worldwide Dissemination of the blaOXA-23Carbapenemase Gene of Acinetobacter baumannii 1
Mugnier, P. D., Poirel, L., Naas, T., & Nordmann, P. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1601.090852 · Cited by 431
Bacterial resistance to antibiotics: Modified target sites
LAMBERT, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.003 · Cited by 424
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Durante-Mangoni, E., Signoriello, G., Andini, R., Mattei, A., De Cristoforo, M., Murino, P., Bassetti, M., Malacarne, P., Petrosillo, N., Galdieri, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit253 · Cited by 405
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Izadpanah, A., & Gallo, R. L. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.026 · Cited by 380
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378
Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P., & Périchon, B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-10 · Cited by 366
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
Roca, I., Espinal, P., Vila-Farrés, X., & Vila, J. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00148 · Cited by 363
Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., & Courvalin, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-07 · Cited by 357
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Isolation of Acinetobacter from Soil and Water
Baumann, P. (1968) · Journal of Bacteriology · doi:10.1128/jb.96.1.39-42.1968 · Cited by 330
Antimicrobial resistance of Acinetobacter spp. in Europe
Van Looveren, M., & Goossens, H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00942.x · Cited by 327
Russo, T. A., Luke, N. R., Beanan, J. M., Olson, R., Sauberan, S. L., MacDonald, U., Schultz, L. W., Umland, T. C., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00366-10 · Cited by 324
Acinetobacter infection – an emerging threat to human health
Visca, P., Seifert, H., & Towner, K. J. (2011) · IUBMB Life · doi:10.1002/iub.534 · Cited by 324
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
Cisneros, J. M., & Rodríguez-Baño, J. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00487.x · Cited by 322
Regulation of Acinetobacter Baumannii Biofilm Formation
Gaddy, J. A., & Actis, L. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.5 · Cited by 321
Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles
Vallenet, D., Nordmann, P., Barbe, V., Poirel, L., Mangenot, S., Bataille, E., Dossat, C., Gas, S., Kreimeyer, A., Lenoble, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001805 · Cited by 314
Zavascki, A. P., Carvalhaes, C. G., Picão, R. C., & Gales, A. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.108 · Cited by 312
Falagas, M. E., & Kopterides, P. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.04.015 · Cited by 305
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Tomaras, A. P., Flagler, M. J., Dorsey, C. W., Gaddy, J. A., & Actis, L. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/019471-0 · Cited by 290
Importance of integrons in the diffusion of resistance
Carattoli, A. (2001) · Veterinary Research · doi:10.1051/vetres:2001122 · Cited by 287
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
Garnacho-Montero, J., Ortiz-Leyba, C., Fernández-Hinojosa, E., Aldabó-Pallás, T., Cayuela, A., Marquez-Vácaro, J. A., Garcia-Curiel, A., & Jiménez-Jiménez, F. J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2598-0 · Cited by 276
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
Iacono, M., Villa, L., Fortini, D., Bordoni, R., Imperi, F., Bonnal, R. J. P., Sicheritz-Ponten, T., De Bellis, G., Visca, P., Cassone, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01643-07 · Cited by 273
Falagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Emergence of NDM-1-producing Acinetobacter baumannii in China
Chen, Y., Zhou, Z., Jiang, Y., & Yu, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr082 · Cited by 271
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Brossard, K. A., & Campagnari, A. A. (2012) · Infection and Immunity · doi:10.1128/iai.05913-11 · Cited by 266
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
The Human Microbiome Project in 2011 and Beyond
Proctor, L. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.001 · Cited by 265
Gerner-smidt, P., Hyyti�-trees, E., & Rota, P. A. (2011) · Manual of Clinical Microbiology · doi:10.1128/9781555816728.ch8 · Cited by 259
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
Peleg, A. Y., Adams, J., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257
Hood, M. I., Mortensen, B. L., Moore, J. L., Zhang, Y., Kehl-Fie, T. E., Sugitani, N., Chazin, W. J., Caprioli, R. M., & Skaar, E. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003068 · Cited by 255
Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles
Jin, J. S., Kwon, S.-O., Moon, D. C., Gurung, M., Lee, J. H., Kim, S. I., & Lee, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017027 · Cited by 255
Playford, E. G., Craig, J. C., & Iredell, J. R. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.11.010 · Cited by 251
Riccio, M. L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G., & Rossolini, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1229-1235.2000 · Cited by 249
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications
Rodríguez-Baño, J., Martí, S., Soto, S., Fernández-Cuenca, F., Cisneros, J. M., Pachón, J., Pascual, A., Martínez-Martínez, L., McQueary, C., Actis, L. A., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01916.x · Cited by 248
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Martinez-Freijo, P., Fluit, A. C., Schmitz, F. J., Grek, V. S., Verhoef, J., & Jones, M. E. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.689 · Cited by 245
Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
Antunes, L. C. S., Imperi, F., Carattoli, A., & Visca, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022674 · Cited by 244
Karthikeyan, K., Thirunarayan, M. A., & Krishnan, P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq273 · Cited by 243
Ruzin, A., Keeney, D., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238
Vahaboglu, H., Oztürk, R., Aygün, G., Coşkunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K., & Otkun, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2265 · Cited by 236
Nemec, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45716-0 · Cited by 226
Brown, S., Young, H. K., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01016.x · Cited by 225
AYDEMIR, H., AKDUMAN, D., PISKIN, N., COMERT, F., HORUZ, E., TERZI, A., KOKTURK, F., ORNEK, T., & CELEBI, G. (2013) · Epidemiology and Infection · doi:10.1017/s095026881200194x · Cited by 225
Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions
Eijkelkamp, B. A., Hassan, K. A., Paulsen, I. T., & Brown, M. H. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-126 · Cited by 220
Microbiome Diversity in the Bronchial Tracts of Patients with Chronic Obstructive Pulmonary Disease
Cabrera-Rubio, R., Garcia-Núñez, M., Setó, L., Antó, J. M., Moya, A., Monsó, E., & Mira, A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00767-12 · Cited by 214
Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
Jacobs, A. C., Hood, I., Boyd, K. L., Olson, P. D., Morrison, J. M., Carson, S., Sayood, K., Iwen, P. C., Skaar, E. P., & Dunman, P. M. (2010) · Infection and Immunity · doi:10.1128/iai.00889-09 · Cited by 214
Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii
Smani, Y., Fàbrega, A., Roca, I., Sánchez-Encinales, V., Vilà, J., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-13 · Cited by 212
Anthony, K. B., Fishman, N. O., Linkin, D. R., Gasink, L. B., Edelstein, P. H., & Lautenbach, E. (2008) · Clinical Infectious Diseases · doi:10.1086/526775 · Cited by 210
Lu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., Golmard, J.-L., & Rouby, J.-J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31827515de · Cited by 207
Pfeifer, Y., Wilharm, G., Zander, E., Wichelhaus, T. A., Göttig, S., Hunfeld, K.-P., Seifert, H., Witte, W., & Higgins, P. G. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr256 · Cited by 207
Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp
Poirel, L., Figueiredo, S., Cattoir, V., Carattoli, A., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01304-07 · Cited by 205
Lolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Simor, A. E., Lee, M., Vearncombe, M., Jones-Paul, L., Barry, C., Gomez, M., Fish, J. S., Cartotto, R. C., Palmer, R., & Louie, M. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/502046 · Cited by 198
Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., & Quale, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm129 · Cited by 192
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 189
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Kwon, K. T., Oh, W. S., Song, J.-H., Chang, H.-H., Jung, S.-I., Kim, S.-W., Ryu, S. Y., Heo, S. T., Jung, D. S., Rhee, J.-Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl499 · Cited by 188
Ploy, M.-C., Denis, F., Courvalin, P., & Lambert, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2684-2688.2000 · Cited by 185
Batirel, A., Balkan, I. I., Karabay, O., Agalar, C., Akalin, S., Alici, O., Alp, E., Altay, F. A., Altin, N., Arslan, F., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2070-6 · Cited by 182
Henry, R., Vithanage, N., Harrison, P., Seemann, T., Coutts, S., Moffatt, J. H., Nation, R. L., Li, J., Harper, M., Adler, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05191-11 · Cited by 181
Deng, M., Zhu, M.-H., Li, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01727-13 · Cited by 176
Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii : a Case-Control Study
Lee, S.-O., Kim, N. J., Choi, S.-H., Kim, T. H., Chung, J.-W., Woo, J.-H., Ryu, J., & Kim, Y. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.224-228.2004 · Cited by 175
Aranda, J., Bardina, C., Beceiro, A., Rumbo‐Feal, S., Cabral, M. P., Barbé, J., & Bou, G. (2011) · Journal of Bacteriology · doi:10.1128/jb.00389-11 · Cited by 173
Pannek, S., Higgins, P. G., Steinke, P., Jonas, D., Akova, M., Bohnert, J. A., Seifert, H., & Kern, W. V. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl081 · Cited by 168
Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe
Bonnin, R. A., Poirel, L., Naas, T., Pirš, M., Seme, K., Schrenzel, J., & Nordmann, P. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03928.x · Cited by 167
Karaiskos, I., Galani, L., Baziaka, F., & Giamarellou, H. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.006 · Cited by 166
Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity
Choi, C. H., Hyun, S. H., Lee, J. Y., Lee, J. S., Lee, Y. S., Kim, S. A., Chae, J.-P., Yoo, S. M., & Lee, J. C. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01041.x · Cited by 166
Wang, S. H., Sheng, W., Chang, Y.-Y., Wang, L., Lin, H.-Y., Chen, M. L., Pan, H.-J., Ko, W.-J., Chang, S., & Lin, F. Y. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1348 · Cited by 164
Yum, J. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf043 · Cited by 163
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn434 · Cited by 163
Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii
Snitkin, E. S., Zelazny, A. M., Montero, C. I., Stock, F., Mijares, L. A., Program, N. C. S., Murray, P. R., Segre, J. A., Mullikin, J. C., Blakesley, R. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104404108 · Cited by 158
Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells
Lee, J. C., Koerten, H. K., van den Broek, P., Beekhuizen, H., Wolterbeek, R., van den Barselaar, M., van der Reijden, T., van der Meer, J., van de Gevel, J. S., & Dijkshoorn, L. (2005) · Research in Microbiology · doi:10.1016/j.resmic.2005.09.011 · Cited by 157
OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii
Sugawara, E., & Nikaido, H. (2012) · Journal of Bacteriology · doi:10.1128/jb.00435-12 · Cited by 157
Feng, X., Sambanthamoorthy, K., Palys, T. J., & Paranavitana, C. M. (2013) · Peptides · doi:10.1016/j.peptides.2013.09.007 · Cited by 151
Gordon, N. C., & Wareham, D. W. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn555 · Cited by 148
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
Hornsey, M., Ellington, M. J., Doumith, M., Thomas, C. P., Gordon, N. C., Wareham, D. W., Quinn, J. P., Lolans, K., Livermore, D. M., & Woodford, N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq218 · Cited by 146
Turton, J. F., Kaufmann, M. E., Glover, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3074-3082.2005 · Cited by 146
Srinivasan, V. B., Rajamohan, G., & Gebreyes, W. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00748-09 · Cited by 145
Mugnier, P. D., Poirel, L., & Nordmann, P. (2009) · Journal of Bacteriology · doi:10.1128/jb.01258-08 · Cited by 145
Rosenfeld, N., Bouchier, C., Courvalin, P. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06422-11 · Cited by 143
Roca, I., Martí, S., Espinal, P., Martínez, P., Gibert, I., & Vilà, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00584-09 · Cited by 138
Sheng, W., Liao, C., Lauderdale, T.-L. Y., Ko, W., Chen, Y.-S., Liu, J.-W., Lau, Y.-J., Wang, L.-S., Liu, K.-S., Tsai, T.-Y., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.02.2254 · Cited by 136
Baraibar, J., Correa, H., Mariscal, D., Gallego, M., Vallés, J., & Rello, J. (1997) · CHEST Journal · doi:10.1378/chest.112.4.1050 · Cited by 135
Fattahian, Y., Rasooli, I., Gargari, S. L. M., Rahbar, M. R., Astaneh, S. D. A., & Amani, J. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.09.004 · Cited by 135
Siroy, A., Molle, V., Guillier, C., Vallenet, D., Pestel‐Caron, M., Cozzone, A. J., Jouenne, T., & Dé, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4876-4883.2005 · Cited by 132
Chen, T.-L., Lee, Y., Kuo, S., Hsueh, P., Chang, F., Siu, L.-K. K., Ko, W., & Fung, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00764-10 · Cited by 131
Héritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Chuang, Y., Cheng, C., Sheng, W., Sun, H., Wang, J., Chen, Y., & Chang, S. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-102 · Cited by 125
Lin, M.-F., Lin, Y.-Y., Yeh, H.-W., & Lan, C. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-119 · Cited by 124
Self-citationHornsey, M., Loman, N. J., Wareham, D. W., Ellington, M. J., Pallen, M. J., Turton, J. F., Underwood, A. P., Gaulton, T., Thomas, C. P., Doumith, M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr168 · Cited by 123
Zhou, H., Zhang, T., Yu, D., Pi, B., Yang, Q., Zhou, J., Hu, S., & Yu, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01134-10 · Cited by 122
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh427 · Cited by 120
Wieczorek, P., Sacha, P., Hauschild, T., Żórawski, M., Krawczyk, M., & Tryniszewska, E. A. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0056-x · Cited by 120
Gu, B., Tong, M., WenJun, Z., Liu, G., Ning, M., Pan, S., & Zhao, W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01318-06 · Cited by 118
Rajamohan, G., Srinivasan, V. B., & Gebreyes, W. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq195 · Cited by 118
Adams, M. D., Chan, E. R., Molyneaux, N., & Bonomo, R. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-10 · Cited by 116
Young, L. S., Sabel, A. L., & Price, C. S. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/521660 · Cited by 112
Kuo, L.-C., Lai, C., Liao, C., Hsu, C.-K., Chang, Y.-L., Chang, C.-Y., & Hsueh, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01601.x · Cited by 110
VEB-1 Extended-Spectrum β-lactamase–producingAcinetobacter baumannii, France
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1708.051547 · Cited by 110
Novel Insights about Class 2 Integrons from Experimental and Genomic Epidemiology
Soledad, M., Piñeiro, S. A., & Centrón, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01392-08 · Cited by 108
Kuo, S., Chang, S., Wang, H., Lai, J., Chen, P., Shiau, Y., Huang, I., & Lauderdale, T.-L. Y. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-200 · Cited by 107
Attributable Mortality of Nosocomial Acinetobacter Bacteremia
Grupper, M., Sprecher, H., Mashiach, T., & Finkelstein, R. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512629 · Cited by 107
Kohlenberg, A., Brümmer, S., Higgins, P. G., Sohr, D., Piening, B., de Grahl, C., Halle, E., Rüden, H., & Seifert, H. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.012302-0 · Cited by 107
Mussi, M. A., Relling, V. M., Limansky, A. S., & Viale, A. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.10.063 · Cited by 107
Chagas, T. P. G., Carvalho, K. R., Santos, I. C. D. O., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.03.006 · Cited by 105
Lu, P., Doumith, M., Livermore, D. M., Chen, T.-P., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn553 · Cited by 104
Coelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 104
Sun, J., Perng, C., Chan, M.-C., Morita, Y., Lin, J., Su, C.-M., Wang, W., Chang, T.-Y., & Chiueh, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049534 · Cited by 103
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl130 · Cited by 102
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
Tsakris, A., Ikonomidis, A., Pournaras, S., TZOUVELEKIS, L. S., Sofianou, D., Legakis, N. J., & Maniatis, A. N. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051097 · Cited by 101
López-Cortés, L. F., Cisneros, J. M., Fernández-Cuenca, F., Bou, G., Tomás, M., Garnacho‐Montero, J., Pascual, Á., Martı́nez-Martı́nez, L., Vilà, J., Pachón, J., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku233 · Cited by 100
Krizova, L., Poirel, L., Nordmann, P., & Nemec, A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt275 · Cited by 100
Mortensen, B. L., & Skaar, E. P. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00095 · Cited by 99
Falagas, M. E., & Karveli, E. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01596.x · Cited by 99
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
Lautenbach, E., Synnestvedt, M. B., Weiner, M. G., Bilker, W. B., Vo, L., Schein, J. R., & Kim, M. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/648450 · Cited by 99
Křížová, L., Dijkshoorn, L., & Nemec, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00221-11 · Cited by 99
Kalın, G., Alp, E., Akin, A., Coskun, R., & Doğanay, M. (2013) · Infection · doi:10.1007/s15010-013-0495-y · Cited by 97
Quinupristin-Dalfopristin Resistance among Gram-Positive Bacteria in Taiwan
Luh, K., Hsueh, P., Teng, L., Pan, H., Chen, Y.-C., Lu, J., Wu, J., & Ho, S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3374-3380.2000 · Cited by 97
Scheetz, M. H., Qi, C., Warren, J. R., Postelnick, M. J., Zembower, T., Obias, A. A., & Noskin, G. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01099-06 · Cited by 96
Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals
Villegas, M. V., Kattán, J. N., Correa, A., Lolans, K., Guzmán, A. M., Woodford, N., Livermore, D. M., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-07 · Cited by 93
Huang, L.-Y., Chen, T.-L., Lu, P., Tsai, C.-A., Cho, W.-L., Chang, F. ‐., Fung, C., & Siu, L.-K. K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02077.x · Cited by 92
Identification of an OprD Homologue in Acinetobacter baumannii
Dupont, M., Pagès, J., Lafitte, D., Siroy, A., & Bollet, C. (2005) · Journal of Proteome Research · doi:10.1021/pr050143q · Cited by 92
Wang, L., Liu, X., Huang, J., Zhu, D., Li, J., & Zhang, J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-109 · Cited by 92
Cho, Y. J., Moon, D. C., Jin, J. S., Choi, C. H., Lee, Y. C., & Lee, J. C. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.02.010 · Cited by 91
Chopra, T., Marchaim, D., Awali, R. A., Krishna, A., Johnson, P., Tansek, R., Chaudary, K., Lephart, P., Slim, J., Hothi, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-13 · Cited by 91
Taitt, C. R., Łęski, T. A., Stockelman, M. G., Craft, D. W., Zurawski, D. V., Kirkup, B. C., & Vora, G. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01897-13 · Cited by 89
Huang, S.-T., Chiang, M.-C., Kuo, S., Lee, Y., Chiang, T.-H., Yang, S.-P., Ti-Yin, Chen, T.-L., & Fung, C.-P. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.12.009 · Cited by 88
Growth of Acinetobacter baumannii in Pellicle Enhanced the Expression of Potential Virulence Factors
Martí, S., Chabane, Y. N., Alexandre, S., Coquet, L., Vilà, J., Jouenne, T., & Dé, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026030 · Cited by 87
Catel‐Ferreira, M., Coadou, G., Molle, V., Mugnier, P. D., Nordmann, P., Siroy, A., Jouenne, T., & Dé, E. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr267 · Cited by 87
Robenshtok, E., Paul, M., Leibovici, L., Fraser, A., Pitlik, S. D., Ostfeld, I., Samra, Z., Perez, S., Lev, B., & Weinberger, M. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.025 · Cited by 86
Brown, S., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01096.x · Cited by 78
Moffatt, J. H., Harper, M., Mansell, A. S., Crane, B., Fitzsimons, T. C., Nation, R. L., Li, J., Adler, B., & Boyce, J. D. (2012) · Infection and Immunity · doi:10.1128/iai.01362-12 · Cited by 78
Chan, P., Huang, L., Lin, H.-C., Chang, L., Chen, M., Lu, C., Lee, P., Chen, J.-M., Lee, C., Pan, H.-J., et al. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/513120 · Cited by 77
Efflux Pumps and Nosocomial Antibiotic Resistance: A Primer for Hospital Epidemiologists
Weinstein, R. A., & Hooper, D. C. (2005) · Clinical Infectious Diseases · doi:10.1086/430381 · Cited by 77
Zheng, Y., Yu, W. C., Zhou, L., Ye, M.-L., Liu, S., Xu, C., He, Y.-Q., & Chen, J. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.01.006 · Cited by 75
Hou, P., Chen, X. Y., Yan, G. F., Wang, Y. P., & Ying, C. M. (2012) · Chemotherapy · doi:10.1159/000335599 · Cited by 74
Novel Resistance-Nodulation-Cell Division Efflux System AdeDE in Acinetobacter Genomic DNA Group 3
Chau, S.-L., Chu, Y.-W., & Houang, E. T. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.4054-4055.2004 · Cited by 73
Özgür, E. S., Horasan, E. Ş., Karaca, K., Ersöz, G., Naycı, S. A., & Ali Hakan, K. A. Y. A. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.09.003 · Cited by 72
Principe, L., Piazza, A., Giani, T., Bracco, S., Caltagirone, M. S., Arena, F., Nucleo, E., Tammaro, F., Rossolini, G. M., Pagani, L., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00291-14 · Cited by 68
Tada, T., Miyoshi‐Akiyama, T., Shimada, K., Shimojima, M., & Kirikae, T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01212-13 · Cited by 65
Su, C.-H., Wang, J., Hsiung, C. A., Chien, L., Chi, C., Yu, H.-T., Chang, F., & Chang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037788 · Cited by 65
Ribera, A., Roca, I., Ruiz, J., Gibert, I., & Vila, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg344 · Cited by 65
Lee, Y., Kim, C., Lee, H., Jeong, S. H., Yong, D., & Lee, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01672-09 · Cited by 65
Kim, Y. J., Kim, S. I., Kim, Y. R., Hong, K., Wie, S., Park, Y. J., Jeong, H., & Kang, M. W. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811000744 · Cited by 64
Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
Chu, H., Zhao, L., Wang, M., Liu, Y., Gui, T., & Zhang, J. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.10.029 · Cited by 64
Lee, Y.-T., Tsao, S.-M., & Hsueh, P. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1870-4 · Cited by 62
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Feliu, A., Ruiz, J., & Vilà, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2310-2312.2003 · Cited by 59
Barbut, F., Yezli, S., Mimoun, M., Pham, J., Chaouat, M., & Otter, J. A. (2012) · Burns · doi:10.1016/j.burns.2012.07.007 · Cited by 58
Lin, C.-C., Liu, T.-C., Kuo, C.-F., Liu, C.-P., & Lee, C.-M. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60050-3 · Cited by 56
Lauderdale, T.-L. Y., McDonald, L. C., Shiau, Y., Chen, P., Wang, H., Lai, J., & Ho, M. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2003.10.005 · Cited by 56
Kim, C., Lee, Y., Lee, H., Woo, G.-J., Song, W., Kim, M., Lee, W. G., Jeong, S. H., Lee, K., & Chong, Y. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.07.014 · Cited by 55
Ng, T. M., Teng, C. B., Lye, D. C., & Apisarnthanarak, A. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/674387 · Cited by 54
Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter Baumannii
Esterly, J. S., Richardson, C. L., Eltoukhy, N., Qi, C., & Scheetz, M. H. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p084 · Cited by 51
Potron, A., Poirel, L., Croizé, J., Chanteperdrix, V., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01164-08 · Cited by 50
Yılmaz, E. M., Sünbül, M., Aksoy, A., Yılmaz, H., Güney, A. K., & Güvenç, T. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.06.003 · Cited by 50
Higgins, P. G., Janßen, K., Fresen, M. M., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01759-12 · Cited by 48
Yamamoto, M., Nagao, M., Matsumura, Y., Matsushima, A., Ito, Y., Takakura, S., & Ichiyama, S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr336 · Cited by 46
Cited by
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review
Gedefie, A., Demsiss, W., Belete, M. A., Kassa, Y., Tesfaye, M., Tilahun, M., Bisetegn, H., & Sahle, Z. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s332051 · Cited by 351
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Vázquez-López, R., Solano-Gálvez, S. G., Juárez Vignon-Whaley, J. J., Abello Vaamonde, J. A., Padró Alonzo, L. A., Rivera Reséndiz, A., Muleiro Álvarez, M., Vega López, E. N., Franyuti-Kelly, G., Álvarez-Hernández, D. A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040205 · Cited by 296
Nguyen, M., & Joshi, S. G. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15130 · Cited by 259
Ma, S., Shungin, D., Mallick, H., Schirmer, M., Nguyen, L. H., Kolde, R., Franzosa, E., Vlamakis, H., Xavier, R., & Huttenhower, C. (2022) · Genome biology · doi:10.1186/s13059-022-02753-4 · Cited by 164
Metadata
- Authors
- Lin, M.-F.
- Venue
- World Journal of Clinical Cases
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 2
- Issue
- 12
- Pages
- 787
- ISSN
- 2307-8960 (ISSN-L)
- OpenAlex
- W2047365652
- Cited by
- 357
- References
- 215
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.